Frank Steven
Insider CIK 1583886 · XON Director · BCRX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2026-08-31 | 2026-09-02 | 1,288 | $9.70 | $12.5K | 36,747 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2026-08-31 | 2026-09-02 | 1,288 | $9.70 | $12.5K | 36,747 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2026-06-11 | 2026-06-15 | 33,540 | — | $0 | 33,540 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2026-06-11 | 2026-06-15 | 15,294 | — | $0 | 35,459 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2026-05-29 | 2026-06-02 | 1,262 | $8.91 | $11.2K | 20,165 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise deriv | 2026-03-13 | 2026-03-16 | 71,839 | — | $0 | 0 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise | 2026-03-13 | 2026-03-16 | 71,839 | — | $0 | 1,226,391 | SEC↗ |
| PGEN PRECIGEN, INC. | A Award deriv | 2026-03-10 | 2026-03-12 | 41,073 | — | $0 | 41,073 | SEC↗ |
| PGEN PRECIGEN, INC. | A Award deriv | 2026-03-10 | 2026-03-12 | 35,612 | — | $0 | 35,612 | SEC↗ |
| PGEN PRECIGEN, INC. | A Award | 2026-03-10 | 2026-03-12 | 14,245 | $3.51 | $50.0K | 1,154,552 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2026-02-27 | 2026-03-03 | 1,285 | $8.75 | $11.2K | 18,903 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2025-11-28 | 2025-12-02 | 1,566 | $7.18 | $11.2K | 17,618 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2025-08-29 | 2025-09-03 | 1,353 | $8.31 | $11.2K | 16,052 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2025-06-12 | 2025-06-16 | 27,181 | — | $0 | 27,181 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2025-06-12 | 2025-06-16 | 12,500 | — | $0 | 14,699 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2025-05-30 | 2025-06-03 | 333 | $10.75 | $3.6K | 2,199 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award deriv | 2025-05-02 | 2025-05-06 | 4,079 | — | $0 | 4,079 | SEC↗ |
| BCRX BIOCRYST PHARMACEUTICALS I | A Award | 2025-05-02 | 2025-05-06 | 1,866 | — | $0 | 1,866 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise deriv | 2025-03-14 | 2025-03-17 | 87,412 | — | $0 | 0 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise | 2025-03-14 | 2025-03-17 | 87,412 | — | $0 | 1,140,307 | SEC↗ |
| PGEN PRECIGEN, INC. | A Award deriv | 2025-03-13 | 2025-03-17 | 71,839 | — | $0 | 71,839 | SEC↗ |
| PGEN PRECIGEN, INC. | A Award deriv | 2025-03-13 | 2025-03-17 | 83,517 | — | $0 | 83,517 | SEC↗ |
| PGEN PRECIGEN, INC. | A Award | 2025-03-13 | 2025-03-17 | 28,735 | $1.74 | $50.0K | 1,052,895 | SEC↗ |
| PGEN PRECIGEN, INC. | A Award deriv | 2024-03-14 | 2024-03-18 | 87,412 | — | $0 | 87,412 | SEC↗ |
| PGEN PRECIGEN, INC. | A Award deriv | 2024-03-14 | 2024-03-18 | 101,626 | — | $0 | 101,626 | SEC↗ |
| PGEN PRECIGEN, INC. | A Award | 2024-03-14 | 2024-03-18 | 34,965 | $1.43 | $50.0K | 1,024,160 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise deriv | 2024-03-09 | 2024-03-12 | 106,837 | — | $0 | 0 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise | 2024-03-09 | 2024-03-12 | 106,837 | — | $0 | 989,195 | SEC↗ |
| PGEN PRECIGEN, INC. | P Buy | 2023-08-14 | 2023-08-15 | 400,000 | $1.72 | $688.0K | 882,358 | SEC↗ |
| PGEN PRECIGEN, INC. | A Award deriv | 2023-03-09 | 2023-03-13 | 106,837 | — | $0 | 106,837 | SEC↗ |
| PGEN PRECIGEN, INC. | A Award deriv | 2023-03-09 | 2023-03-13 | 125,489 | — | $0 | 125,489 | SEC↗ |
| PGEN PRECIGEN, INC. | A Award | 2023-03-09 | 2023-03-13 | 42,735 | $1.17 | $50.0K | 482,358 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise deriv | 2023-02-22 | 2023-02-24 | 61,576 | — | $0 | 0 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise | 2023-02-22 | 2023-02-24 | 61,576 | — | $0 | 439,623 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise deriv | 2022-03-25 | 2022-03-29 | 16,212 | — | $0 | 0 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise | 2022-03-25 | 2022-03-29 | 16,212 | — | $0 | 378,047 | SEC↗ |
| PGEN PRECIGEN, INC. | A Award deriv | 2022-02-22 | 2022-02-24 | 83,189 | — | $0 | 83,189 | SEC↗ |
| PGEN PRECIGEN, INC. | A Award deriv | 2022-02-22 | 2022-02-24 | 61,576 | — | $0 | 61,576 | SEC↗ |
| PGEN PRECIGEN, INC. | A Award | 2022-02-22 | 2022-02-24 | 24,630 | $2.03 | $50.0K | 361,835 | SEC↗ |
| PGEN PRECIGEN, INC. | A Award deriv | 2021-03-25 | 2021-03-29 | 22,107 | — | $0 | 22,107 | SEC↗ |
| PGEN PRECIGEN, INC. | A Award deriv | 2021-03-25 | 2021-03-29 | 16,212 | — | $0 | 16,212 | SEC↗ |
| PGEN PRECIGEN, INC. | A Award | 2021-03-25 | 2021-03-29 | 6,485 | $7.71 | $50.0K | 337,205 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise deriv | 2021-03-13 | 2021-03-16 | 62,189 | — | $0 | 0 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise | 2021-03-13 | 2021-03-16 | 62,189 | — | $0 | 330,720 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise deriv | 2021-03-03 | 2021-03-05 | 2,968 | — | $0 | 0 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise | 2021-03-03 | 2021-03-05 | 2,968 | $5.69 | $16.9K | 268,531 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise deriv | 2020-06-30 | 2020-07-06 | 2,968 | — | $0 | 0 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise | 2020-06-30 | 2020-07-06 | 2,968 | $3.17 | $9.4K | 265,563 | SEC↗ |
| PGEN PRECIGEN, INC. | A Award deriv | 2020-03-13 | 2020-03-17 | 62,189 | — | $0 | 62,189 | SEC↗ |
| PGEN PRECIGEN, INC. | A Award deriv | 2020-03-13 | 2020-03-17 | 96,324 | — | $0 | 96,324 | SEC↗ |
| PGEN PRECIGEN, INC. | A Award | 2020-03-13 | 2020-03-17 | 24,875 | $2.01 | $50.0K | 262,595 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise deriv | 2020-03-08 | 2020-03-10 | 24,703 | — | $0 | 0 | SEC↗ |
| PGEN PRECIGEN, INC. | M Exercise | 2020-03-08 | 2020-03-10 | 24,703 | — | $0 | 237,720 | SEC↗ |
| XON INTREXON CORP | M Exercise deriv | 2019-03-23 | 2019-03-26 | 7,911 | — | $0 | 0 | SEC↗ |
| XON INTREXON CORP | M Exercise | 2019-03-23 | 2019-03-26 | 7,911 | — | $0 | 213,017 | SEC↗ |
| XON INTREXON CORP | A Award deriv | 2019-03-08 | 2019-03-12 | 42,450 | — | $0 | 42,450 | SEC↗ |
| XON INTREXON CORP | A Award deriv | 2019-03-08 | 2019-03-12 | 24,703 | — | $0 | 32,614 | SEC↗ |
| XON INTREXON CORP | A Award | 2019-03-08 | 2019-03-12 | 9,881 | $5.06 | $50.0K | 205,106 | SEC↗ |
| XON INTREXON CORP | M Exercise deriv | 2019-02-12 | 2019-02-14 | 2,968 | — | $0 | 0 | SEC↗ |
| XON INTREXON CORP | M Exercise | 2019-02-12 | 2019-02-14 | 2,968 | $3.17 | $9.4K | 195,225 | SEC↗ |
| XON INTREXON CORP | A Award deriv | 2018-03-23 | 2018-03-29 | 14,246 | — | $0 | 14,246 | SEC↗ |
| XON INTREXON CORP | A Award deriv | 2018-03-23 | 2018-03-29 | 7,911 | — | $0 | 7,911 | SEC↗ |
| XON INTREXON CORP | A Award | 2018-03-23 | 2018-03-29 | 3,164 | $15.80 | $50.0K | 192,257 | SEC↗ |
| XON INTREXON CORP | M Exercise deriv | 2018-02-12 | 2018-02-14 | 8,906 | — | $0 | 0 | SEC↗ |
| XON INTREXON CORP | M Exercise | 2018-02-12 | 2018-02-14 | 8,906 | $2.64 | $23.5K | 189,093 | SEC↗ |
| XON INTREXON CORP | J Other | 2017-07-24 | 2017-07-26 | 137,146 | — | $0 | 180,187 | SEC↗ |
| XON INTREXON CORP | A Award deriv | 2017-03-16 | 2017-03-20 | 15,000 | — | $0 | 15,000 | SEC↗ |
| XON INTREXON CORP | A Award | 2017-03-16 | 2017-03-20 | 2,806 | — | $0 | 43,041 | SEC↗ |
| XON INTREXON CORP | J Other | 2016-07-29 | 2016-08-02 | 31,294 | — | $0 | 40,235 | SEC↗ |
| XON INTREXON CORP | A Award deriv | 2016-03-10 | 2016-03-14 | 15,000 | — | $0 | 15,000 | SEC↗ |
| XON INTREXON CORP | A Award | 2016-03-10 | 2016-03-14 | 1,714 | $34.99 | $60.0K | 8,941 | SEC↗ |
| XON INTREXON CORP | A Award deriv | 2015-03-12 | 2015-03-23 | 15,000 | — | $0 | 15,000 | SEC↗ |
| XON INTREXON CORP | A Award | 2015-03-12 | 2015-03-23 | 1,263 | $47.48 | $60.0K | 7,227 | SEC↗ |
| XON INTREXON CORP | A Award deriv | 2014-03-20 | 2014-03-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| XON INTREXON CORP | A Award | 2014-03-20 | 2014-03-24 | 1,953 | $30.72 | $60.0K | 5,964 | SEC↗ |
| XON INTREXON CORP | A Award | 2014-01-20 | 2014-01-22 | 20 | $36.82 | $736 | 4,011 | SEC↗ |
| XON INTREXON CORP | A Award | 2013-12-17 | 2013-12-18 | 75 | $19.83 | $1.5K | 3,991 | SEC↗ |
| XON INTREXON CORP | A Award | 2013-10-31 | 2013-11-04 | 35 | $21.20 | $742 | 3,916 | SEC↗ |
| XON INTREXON CORP | A Award | 2013-10-27 | 2013-10-29 | 34 | $22.02 | $749 | 3,881 | SEC↗ |
| XON INTREXON CORP | A Award | 2013-09-10 | 2013-09-12 | 56 | $26.76 | $1.5K | 3,847 | SEC↗ |